Evaluation of Fluoroquinolone Resistance in Clinical Avian Pathogenic Escherichia coli Isolates from Flanders (Belgium)

Antibiotics
Robin TemmermanMathias Devreese

Abstract

Fluoroquinolones are frequently used antimicrobials for the treatment of avian pathogenic Escherichia coli (APEC) infections. However, rapid development and selection of resistance to this class of antimicrobial drugs is a significant problem. The aim of this study was to investigate the occurrence and mechanisms of antimicrobial resistance against enrofloxacin (ENRO) in APEC strains in Flanders, Belgium. One hundred and twenty-five APEC strains from broilers with clinical colibacillosis were collected in Flanders from November 2017 to June 2018. The minimum inhibitory concentration (MIC) of all strains and the mutant prevention concentration (MPC) of a sample of sensitive isolates were determined using a commercial gradient strip test and via the agar dilution method, respectively. Non-wild type (NWT) isolates were further characterized using polymerase chain reaction (PCR), gel electrophoresis and gene sequencing. Forty percent of the APEC strains were NWT according to the epidemiological cut-off (ECOFF) measure (MIC > 0.125 μg/mL). With respect to clinical breakpoints, 21% were clinically intermediate (0.5 ≤ MIC ≤ 1 μg/mL) and 10% were clinically resistant (MIC ≥ 2). The MPC values of the tested strains ranged from 0.064 to ...Continue Reading

References

Jun 1, 1990·Antimicrobial Agents and Chemotherapy·H YoshidaS Nakamura
Mar 31, 1998·Lancet·L Martínez-MartínezG A Jacoby
Oct 3, 1998·Antimicrobial Agents and Chemotherapy·L M WeigelF C Tenover
Feb 13, 2001·Antimicrobial Agents and Chemotherapy·J M BlondeauK Drlica
Feb 27, 2001·The Journal of Antimicrobial Chemotherapy·E GiraudE Chaslus-Dancla
Oct 10, 2002·The Veterinary Record·F VandemaeleB M Goddeeris
Mar 26, 2003·The Journal of Antimicrobial Chemotherapy·Yolanda SáenzCarmen Torres
Jun 14, 2003·The Journal of Antimicrobial Chemotherapy·Karl Drlica
Jul 3, 2003·The Journal of Antimicrobial Chemotherapy·Gunnar KahlmeterAlkiviadis Vatopoulos
Jul 10, 2004·The Journal of Antimicrobial Chemotherapy·L P RandallM J Woodward
Apr 30, 2005·The Journal of Antimicrobial Chemotherapy·Linda L MarcussonDiarmaid Hughes
Jul 28, 2006·Antimicrobial Agents and Chemotherapy·A RobicsekD C Hooper
Aug 3, 2007·American Journal of Veterinary Research·Qianxue LiXuming Deng
Feb 21, 2008·Antimicrobial Agents and Chemotherapy·Kunikazu YamaneYoshichika Arakawa
Sep 11, 2008·Current Drug Targets·Ciara Walsh, Séamus Fanning
Oct 14, 2009·Clinical Microbiology Reviews·Jacob StrahilevitzAri Robicsek
Mar 3, 2011·FEMS Immunology and Medical Microbiology·Louise BélangerCharles M Dozois
Mar 31, 2012·Preventive Veterinary Medicine·Davy PersoonsFreddy Haesebrouck
Mar 19, 2013·International Journal of Medical Microbiology : IJMM·Alessandra Carattoli
Jul 17, 2013·The Journal of Veterinary Medical Science·Michiko KawanishiTetsuo Asai
May 21, 2014·Trends in Microbiology·Liam S RedgraveLaura J V Piddock
Jul 25, 2015·FEMS Microbiology Letters·Rodrigo Guabiraba, Catherine Schouler
Jan 1, 2014·Frontiers in Veterinary Science·Charlotte CollingwoodPaul Wigley
Jan 19, 2016·Frontiers in Veterinary Science·KaNa SangZongHui Yuan

❮ Previous
Next ❯

Methods Mentioned

BETA
Electrophoresis
genotyping
PCR

Software Mentioned

BLAST
BioNumerics

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.